Found 5 matching trials
Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD) PHASE2 The purpose of this study is to evaluate the efficacy of Fixed Combination ...
Show More Location
Medical Center Convex EOOD
Learn More & Join Trial
Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) Versus Combination of Fluticasone Furoate (FlF)/Vilanterol (VI) + Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) PHASE3 The purpose of the study is to demonstrate the triple combination of beclom...
Show More Location
Erzsebet Gondozohaz
Learn More & Join Trial
Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and the Lung Availability of CHF 5993 in Healthy Volunteers PHASE1 This clinical pharmacology study is performed to evaluate the total systemi...
Show More Location
SGS CPU Antwerpen
Learn More & Join Trial
2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients PHASE3 The aim of the present study is to evaluate the superiority of the fixed tr...
Show More Location
Chiesi Farmaceutici S.p.A.
Learn More & Join Trial
Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI) PHASE3 Primary Objective
• To demonstrate the superiority of CHF 5993 pressurised...
Show More Location
Chiesi clinical Trial Site 156031
Learn More & Join Trial